fhs 74int cells (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
fhs 74int cells
Fhs 74int Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 243 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fhs+74+int/FHs+74+Int/pm41796779-59-0-7
Average 95 stars, based on 243 article reviews
Fhs 74int Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 243 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fhs+74+int/FHs+74+Int/pm41796779-59-0-7
Average 95 stars, based on 243 article reviews
fhs 74int cells - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Transfection:Article Title: RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers. Article Snippet: Oncogenic RAS and RAF signaling has been implicated in contributing to radioresistance in pancreatic and thyroid cancers.. In this study, we sought to better clarify molecular mechanisms contributing to this effect.. We discovered that miRNA 296-3p (miR-296-3p) is significantly correlated with radiosensitivity in a panel of pancreatic cancer cells, and miR-296-3p is highly expressed in normal cells, but low in cancer cell lines. other:Article Title: Epithelial-derived galectin-9 containing exosomes contribute to the immunomodulatory effects promoted by 2’-fucosyllactose and short-chain galacto- and long-chain fructo-oligosaccharides Article Snippet: FHs 74 Int were grown in T25 flasks (Greiner Bio-One, Alphen aan den Rijn, The Netherlands) using Control:Article Title: Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth via BCL-2-mediated intrinsic apoptosis. Article Snippet: Correspondence Mitsuro Kanda, Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.. Email: m-kanda@med.nagoya-u.ac.jp Abstract Despite recent advances in the development of therapeutic antibodies, the prognosis of unresectable or metastatic gastric cancer (GC) remains poor.. Here, we searched for genes involved in the malignant phenotype of GC and investigated the potential of one candidate gene to serve as a novel therapeutic target. |